We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Diabetes and COVID-19: Disease—Management—People.
- Authors
Peric, Slobodan; Stulnig, Thomas M.
- Abstract
Summary: The current pandemic of SARS-CoV‑2 coronavirus disease 2019 (COVID-19) is a particular challenge for diabetes patients. Diabetes mellitus predisposes to a particularly severe course of the disease and doubles the COVID-19 mortality risk due to pulmonary and cardiac involvement. In addition, diabetes patients often suffer from comorbidities which further worsen clinical outcomes. Glycemic control during infectious diseases is often suboptimal, and antidiabetic drugs and insulin therapy have to be adapted accordingly. On the other hand, access of diabetes patients to outpatient clinics are limited during the ongoing season urging alternative treatment options, particularly the implementation of novel telemedicine strategies. Hence, the opportunity of the COVID 19 crisis should be taken to make a significant step forward in the care for diabetes patients.
- Subjects
COVID-19; GLYCEMIC control; COMMUNICABLE diseases; PEOPLE with diabetes; DIABETES
- Publication
Wiener Klinische Wochenschrift, 2020, Vol 132, Issue 13/14, p356
- ISSN
0043-5325
- Publication type
Article
- DOI
10.1007/s00508-020-01672-3